Elena Iusupovskaia

Elena Iusupovskaia

Auto-generated profile, based on publicly available information

Elena Iusupovskaia

Institute for Bionic Technologies and Engineering

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 July 2025 in Journal of Neuro-Oncology
Verified
Journal Article
Closed access
PDF file
EIE. Iusupovskaia
E. Iusupovskaia
NIN. Isaev
N. Isaev
AAA. Antonian
A. Antonian
ABA. K. Boromangnaeva
A. K. Boromangnaeva
Egor KuzminEgor Kuzmin
Egor Kuzmin
Aleksandr MarkovAleksandr Markov
Aleksandr Markov

6 August 2025 in ACS Applied Electronic Materials
Verified
Journal Article
Closed access
EIElena Iusupovskaia
Elena Iusupovskaia
Aleksandr MarkovAleksandr Markov
Aleksandr Markov
AGAlexander Gerasimenko
Alexander Gerasimenko
UKUlyana Kurilova
Ulyana Kurilova
ISIrina Suetina
Irina Suetina
DTDmitry Telyshev
Dmitry Telyshev

17 October 2023 in Safety and Risk of Pharmacotherapy
Verified
Journal Article
Open access
PDF file
SZS. A. Zaveryachev
S. A. Zaveryachev
ELEkaterina Lotnik
Ekaterina Lotnik
MGMariam Gilavian
Mariam Gilavian
EYE. A. Yusupovskaya
E. A. Yusupovskaya
KKKonstantin A Koshechkin
Konstantin A Koshechkin
Scientific relevance. Medication adherence is an important condition for effective and safe treatment. The adherence of patients to prescriptions is tracked by assessing their condition, counting the pills taken, and using other indirect methods. Digital technologies can help healthcare providers improve their patients’ medication adherence.Aim. The authors aimed to review literature describing the medication adherence impact on treatment effectiveness, as well as digital solutions accompanying pharmacotherapy.Discussion. Poor adherence to treatment is a significant risk factor for patients. The most common examples of poor adherence are omissions and delays in the timing of doses. Compared with classical daily dosing, individualised regimens significantly increase the risk of adherence errors. Significant consequences of non-adherence include exacerbation of the disease, insufficient effectiveness of treatment, adverse drug reactions, and drug resistance. Promising hardware and software approaches to supporting medication adherence include innovative technological solutions (pillboxes, bottles with electronic reminder systems, digital pills, and smart medication adherence monitoring systems), mobile apps, and chatbots.Conclusions. Digital solutions to support pharmacotherapy help improve patients’ adherence to their dosing regimens and individualise their treatment. Further research is needed to select the most promising areas and develop novel digital technologies.